Musculoskeletal involvement in systemic sclerosis

被引:1
作者
Wielosz, Ewa [1 ]
Hyla, Marcin Grzegorz [2 ]
机构
[1] Med Univ Lublin, Dept Rheumatol, Syst Connect Tissue Dis & Internal Dis, 8 Jaczewskiego St, PL-20954 Lublin, Poland
[2] Independent Publ Hosp 4, Dept Rheumatol & Syst Connect Tissue Dis, Lublin, Poland
来源
REUMATOLOGIA | 2024年 / 62卷 / 04期
关键词
systemic sclerosis; muscle involvement; joint involvement; INFLAMMATORY ARTHROPATHY; RHEUMATOID-ARTHRITIS; HAND INVOLVEMENT; ULTRASOUND; ANTIBODIES; FREQUENCY; FEATURES; ULTRASONOGRAPHY; SCLERODERMA; DETECT;
D O I
10.5114/reum/190576
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic sclerosis (SSc) is a multi-organ, systemic connective tissue disease, which affects the lungs, heart, gastrointestinal tract, kidneys, skin, and musculoskeletal system. Musculoske-letal involvement is observed in 40-90% of patients with SSc. During the disease, any structure of the musculoskeletal system, such as bones, joints, tendon sheaths, tendons, and muscles, may be affected. The most common symptoms include joint pain, arthritis, tendinitis leading to tendon rup-ture, acro-osteolysis, calcinosis, myalgia, and myositis. Osteo-articular complications and changes in the soft tissues of the hand lead to finger contracture, which causes deterioration of the patients' quality of life and disability. To sum up, a more detailed understanding of the aetiology leading to progressive changes in the musculoskeletal system may contribute to the introduction of new therapeutic options, and thus improve the quality of life and reduce disability in patients with SSc
引用
收藏
页码:274 / 281
页数:8
相关论文
共 52 条
[51]   Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: Prevalence and relationships with joint manifestations [J].
Wielosz, Ewa ;
Majdan, Maria ;
Dryglewska, Magdalena ;
Zwolak, Robert .
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (09) :1253-1257
[52]   Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment [J].
Young A. ;
Namas R. ;
Dodge C. ;
Khanna D. .
Current Treatment Options in Rheumatology, 2016, 2 (3) :252-269